Breaking Down Huafon Chemical Co., Ltd. Financial Health: Key Insights for Investors

Investors monitoring Huafon Chemical Co., Ltd. (002064.SZ) should note key headwinds and offsets: revenue slid to CNY 12.137 billion in H1 2025 (down 11.7% YoY) with TTM revenue at CNY 24.67 billion (an 8.60% YoY decline), Q3 2025 revenue fell to CNY 5.97 billion (-9.89% YoY), yet the company declared an interim cash dividend of CNY 0.50/10 A shares payable Oct 15, 2025; profitability pressures are evident-2024 net profit margin was 8.24% (from 9.42% in 2023) and ROE dropped to 8.39%-but cash metrics show resilience with Q3 2025 operating cash flow surging to CNY 2.93 billion (+198.65% YoY) and cash & equivalents of CNY 7.184 billion, while leverage remains low (debt/equity 0.09), liquidity healthy (current ratio 2.46, quick ratio 1.84), valuation sits at market cap CNY 46.80 billion with P/S 1.90 and P/E 27.21 (forward P/E 21.75), and investors must weigh regulatory and raw-material risks against growth avenues in specialty chemicals, sustainability initiatives and international expansion-read on for detailed breakdowns of revenue drivers, margins, cash flow dynamics, capital structure, valuation multiples and scenario-driven risk analysis.

Huafon Chemical Co., Ltd. (002064.SZ) - Revenue Analysis

• H1 2025 total revenue: CNY 12.137 billion (down 11.7% vs H1 2024)
• Trailing twelve months (TTM) revenue: CNY 24.67 billion (down 8.60% YoY; prior year had +2.41% growth)
• Q3 2025 revenue: CNY 5.97 billion (down 9.89% vs Q3 2024)
• Revenue per employee: ~CNY 2.88 million (workforce: 8,780 employees)
• Market capitalization: CNY 46.80 billion; P/S ratio: 1.90
• Interim cash dividend for 2025: CNY 0.50 per 10 A shares (payable 15 Oct 2025)

• Revenue decline drivers: weak end-market demand, domestic oversupply in materials/spandex, intensified pricing competition.
• Operational insight: revenue per employee (~CNY 2.88M) suggests moderate labor productivity; watch capacity utilization and cost controls.
• Valuation context: market cap CNY 46.80 bn and P/S 1.90 imply the market prices in slower near-term growth but still assigns material value to asset base and cash returns (dividend).

Huafon Chemical Co., Ltd. (002064.SZ) - Profitability Metrics

• Net profit margin: 8.24% (2024) vs. 9.42% (2023) - decline indicates reduced profitability and margin compression.
• Return on equity (ROE): 8.39% (2024) vs. 9.42% (2023) - lower efficiency in converting equity into profit.
• Gross profit margin: under pressure due to higher feedstock/raw-material costs and competitive pricing in spandex.
• Operating profit: declined year-over-year, reflecting higher costs and competitive environment.
• Earnings per share (EPS): Q3 2025 EPS = CNY 0.10 (unchanged YoY Q3), but year-to-date EPS down 29.27% YoY.
• Operating cash flow: CNY 2.93 billion in Q3 2025, up 198.65% YoY - significantly improved cash generation.

Huafon Chemical Co., Ltd. (002064.SZ) - Debt vs. Equity Structure

Huafon Chemical displays a conservative capital structure by traditional leverage metrics, but there are mixed signals beneath the headline ratios that investors should note.

• Debt-to-Equity ratio: 0.09 (2024) - very low financial leverage.
• Current ratio: 2.46 (2024) - adequate short-term liquidity.
• Interest Coverage ratio: 24.69 (2024) - strong ability to service interest from operating income.
• Equity-to-Assets ratio: 73.55% (2024) - solid equity base cushioning obligations.
• Debt-to-Assets ratio: increased in 2024 - indicates rising leverage relative to total assets.

Key considerations for investors:

• Low debt-to-equity and high interest coverage provide resilience against interest-rate volatility.
• Rising debt-to-assets signals increasing leverage - monitor whether this reflects strategic investment or cash-flow stress.
• Despite liquidity and coverage strength, elevated raw material costs and declining profitability constrain financial flexibility and could erode margins if sustained.
• Equity-heavy capitalization (73.55% equity-to-assets) offers a meaningful cushion, but persistent profitability declines could reduce that buffer over time.

Further context and investor positioning can be reviewed here: Exploring Huafon Chemical Co., Ltd. Investor Profile: Who's Buying and Why?

Huafon Chemical Co., Ltd. (002064.SZ) - Liquidity and Solvency

Huafon Chemical's recent cash-flow and solvency metrics point to materially improved liquidity and strong coverage of interest and short-term liabilities. Key figures for Q3 2025 show robust operating cash generation, a healthy cash balance and conservative short-term coverage ratios that reduce refinancing and liquidity risk.

• Operating cash flow (Q3 2025): CNY 2.93 billion - up 198.65% YoY.
• Cash and cash equivalents (Sep 2025): CNY 7.184 billion.
• Quick ratio: 1.84 - ability to cover short-term liabilities without selling inventory.
• Free cash flow per share: CNY 0.6095 - cash available after capital expenditures.
• Operating cash flow per share: CNY 0.74 - operating cash generation normalized per share.
• Interest coverage ratio: 24.69 - strong capacity to meet interest obligations from operating income.

For background on the company's history, ownership and business model, see: Huafon Chemical Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Huafon Chemical Co., Ltd. (002064.SZ) - Valuation Analysis

• P/E (trailing): 27.21 - implies investors pay CNY 27.21 for CNY 1 of last‑twelve‑month earnings.
• Forward P/E: 21.75 - the market expects earnings to improve relative to the trailing period.
• EV/EBITDA: 12.32 - a mid‑range valuation on operational profitability before non‑cash charges and capital structure.
• EV/FCF: 16.03 - value placed on the company's free cash flow generation.
• P/FCF: 18.38 - equity market pricing versus free cash flow available to shareholders.
• P/OCF: 11.94 - market valuation relative to operating cash flow.
• Market cap: CNY 46.80 billion; P/S: 1.90 - investors pay nearly two times annual sales for the equity.

• Relative positioning: P/E and EV/EBITDA place Huafon above commodity chemical averages but in line with higher‑margin specialty suppliers.
• Cash multiples (EV/FCF, P/FCF, P/OCF) signal the market attributes material value to Huafon's cash conversion and capex profile.
• Investors concerned about cyclicality should weigh the forward P/E improvement against sector demand cycles and raw‑material cost volatility.

Huafon Chemical Co., Ltd. (002064.SZ) - Risk Factors

Huafon Chemical faces a mix of regulatory, market, commodity, currency, and operational risks that materially affect its financial profile and outlook. The following section breaks down these risks and attaches relevant company-level metrics to help investors assess potential exposures.

• Regulatory risk: China's tightening environmental regulations on emissions, wastewater and hazardous waste handling increase compliance costs and can force production halts or retrofits. In FY2023 Huafon reported capitalized environmental projects and related compliance capex of approximately RMB 420 million, and recurring environmental operating costs rose ~12% year-over-year.
• Competitive risk: Huafon operates against domestic peers (e.g., Zhejiang Huafon Spandex) and large international firms (Invista, Hyosung). Competitive pressure can compress margins; Huafon's gross margin hovered around 18.5% in FY2023 versus historical peaks above 22% in lower-cost periods.
• Commodity/raw-material risk: Key feedstocks such as benzene and MDI drive COGS. Volatility in benzene prices and MDI spreads can move margins quickly - Huafon estimated that ~30-35% of its direct material cost base is sensitive to benzene/MDI price swings.
• Currency risk: With exports representing roughly 15-20% of revenue (management disclosures pointing to ~18% in 2023), RMB appreciation or USD/EUR volatility can depress reported sales and margins when converted to RMB and may affect competitiveness abroad.
• Market concentration/domestic exposure: Revenue concentration in China leaves the firm exposed to domestic GDP cycles and sector-specific policy. Approximately 80-85% of sales remain domestic, so local slowdowns or policy shifts (e.g., stimulus withdrawal or property-sector weakness) can reduce demand for intermediate chemical products.
• Supply chain & operational disruptions: The COVID-19 pandemic and periodic logistic bottlenecks highlighted risks-plant shutdowns, shipping delays, or raw-material shortages can interrupt production, leading to lost sales and higher working-capital needs. Inventory-to-revenue sensitivity has at times increased working-capital days by 10-20 days during disruptions.

Key quantitative indicators that illustrate how these risks feed into Huafon's financial health:

• How regulations translate to costs: enforced limits on VOCs, stricter effluent standards, and higher disposal fees can raise unit operating costs; management's disclosed environmental capex points to ongoing investments that may recur as standards tighten.
• Competitive margin pressure: product commoditization and capacity additions by competitors could lead to price erosion, especially in commodity polymer segments where Huafon competes on scale and cost efficiency.
• Commodity hedging and procurement: limited ability to fully hedge benzene/MDI exposure means swings feed directly into margins; historically, 6-12 month spikes in feedstock have reduced EBITDA by up to 10-15% in peak episodes.
• Currency and trade exposure: export share (~18%) ties profitability to FX; a stronger RMB reduces export proceeds in RMB terms and may necessitate price adjustments that take time to implement.
• Concentration risk mitigation: diversification into higher value-added products and downstream integration can reduce sensitivity to cyclical volumes, but these moves require capital and time, and execution risk remains.
• Supply chain resiliency: investing in dual sourcing, inventory buffers, and domestic supplier development can reduce disruption risk but increases working-capital needs and may lower short-term ROIC.

For contextual framing of Huafon Chemical's strategic posture and how these risks are managed operationally and culturally, see: Mission Statement, Vision, & Core Values (2026) of Huafon Chemical Co., Ltd.

Huafon Chemical Co., Ltd. (002064.SZ) - Growth Opportunities

• Specialty chemicals shift: management guidance and capital plans show an increasing share of revenue targeted from specialty polymers and value-added spandex derivatives, where gross margins can exceed 20-30% versus commodity spandex margins.
• International expansion: sales initiatives focus on Southeast Asia and Europe, regions where technical spandex and recycled-product demand has grown 8-12% annually in recent years.
• Sustainability roadmap: investments in recycled raw-material lines and lower-emission processes aim to capture premiums from brands requiring eco-certified inputs.

• Cash flow capacity: consistent positive operating cash flow (≈RMB 1.8-2.1bn range) provides funding for organic R&D and moderate M&A without materially increasing leverage.
• Equity buffer: a shareholders' equity base above RMB 10bn yields flexibility for strategic partnerships and bolt-on acquisitions in specialty niches.
• Cost position: scale in spandex production gives Huafon leverage to maintain competitive unit costs during cyclical downturns, supporting margin resilience.

• Progress on specialty product revenue mix - watch management disclosures for target mix (e.g., specialty & recycled >25% of sales over 3-5 years).
• Capex allocation - the split between capacity expansion, recycled-material lines, and R&D will indicate strategic priority.
• Export growth rates - accelerating shipments to Southeast Asia and Europe would validate internationalization claims.
• Sustainability certifications and offtake agreements - commercial agreements with apparel brands signal successful premium capture.